aTYR PHARMA (ATYR) EPS (Diluted) (2019 - 2026)
Powered by 
Analysis
aTYR PHARMA (ATYR) EPS (Diluted) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 12.23 |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -1.96 |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 7.15 |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -0.40 |
| 10 | aTYR PHARMA | 35.31 Mn | -22.30 Mn | - | -0.11 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.12 |
| Dec 31, 2025 | -0.16 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | -0.23 |
| Mar 31, 2025 | -0.18 |
| Dec 31, 2024 | -0.21 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.24 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.25 |
| Mar 31, 2023 | -0.30 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -0.47 |
| Jun 30, 2022 | -0.45 |
| Mar 31, 2022 | -0.46 |
| Dec 31, 2021 | -0.46 |
| Sep 30, 2021 | -0.43 |